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Abstract
Objectives—Despite prevention efforts new HIV diagnoses continue in the Southern US, where
the epidemic is characterized by significant racial/ethnic disparities. We integrated phylogenetic
analyses with clinical data to reveal trends in local HIV transmission.
Design—Cross-sectional analysis of 1671 HIV-infected individuals each with one B-subtype pol
sequence obtained during chronic (82%; UNC Center for AIDS Research Clinical Cohort) or
acute/recent (18%; Duke/UNC Acute HIV Consortium) infection.
Methods—Phylogenies were inferred using neighbor joining to select related sequences then
confirmed with Bayesian methods. We characterized transmission clusters (clades n≥3 sequences
supported by posterior probabilities=1) by factors including race/ethnicity and transmission risk.
Factors associated with cluster membership were evaluated for newly diagnosed patients.
Results—Overall, 72% were male, 59% black and 39% MSM. A total of 557 (33%) sequences
grouped in either 108 pairs (n=216) or 67 clusters (n=341). Clusters ranged from 3–36 (median 4)
members. Composition was delineated primarily by race, with 28% exclusively black, and to a
lesser extent by risk group. Both MSM and heterosexuals formed discrete clusters though
substantial mixing was observed. In multivariable analysis, patients with age ≤30 years (P=0.009),
acute infection (P=0.02), local residence (P=0.002), and transmitted drug resistance (P=0.02) were
more likely to be cluster members while Latinos were less likely (P<0.001).
Conclusions—Integration of molecular, clinical and demographic data offers a unique view into
the structure of local transmission networks. Clustering by black race, youth and TDR and
inability to identify Latino clusters will inform prevention, testing and linkage to care strategies.
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INTRODUCTION
New HIV diagnoses continue in the Southern United States1, the region with the largest
number of AIDS cases in the nation and an above average rate of new diagnoses[1], despite
the presence of comprehensive prevention efforts. As in other Southern states, the HIV
epidemic in North Carolina (NC)is characterized by significant racial and ethnic disparities.
In 2009, blacks accounted for 66% of new infections, with an infection rate over 9 times
higher than whites[2]. Similarly, Latinos represent a growing proportion of the NC
epidemic, with a significant rise from 1% to 8% of new cases between 1995 and 2005[3].
Although HIV testing efforts have increased following calls for routine screening in
2006[4], this has only modestly increased new diagnoses. Additionally, presentation late in
the course of infection remains common[5], particularly among Latinos [6].
The failure to fully reach all individuals at risk for HIV infection, particularly
disenfranchised minorities with limited social mobility, highlights the need for continued
innovative approaches to better understand HIV transmission on a population level.
Prevention programs must target factors contributing to onward HIV transmission locally in
order to successfully diminish HIV incidence. Notably, HIV epidemics are heterogeneous,
composed of a series of overlapping local sub or micro-epidemics defined by risk groups,
temporal variation and localized geographic areas[7–9]. Uncovering these sub-epidemics
early is challenging because HIV is often diagnosed years after transmission, making
identification of the actual source or mode of exposure difficult. HIV sequence data can be
used to characterize the structure of epidemics[10, 11] and when paired with epidemiologic
data may provide unique insights into groups responsible for ongoing transmission [12].
This approach to HIV epidemiology is now possible through advances in genomic
sequencing, statistical methods, and computational speed[13]. Utilizing HIV pol sequences,
derived from genotypes sent during clinical care, results in increased sampling density to
uncover trends in transmission at the population level[11, 14].
The objective of this study was to use phylogenetic analyses of HIV pol sequences in
conjunction with clinical and demographic data to identify which groups in NC contribute to
ongoing HIV transmission – a complementary approach to understanding HIV propagation
which may otherwise be invisible by patient history alone. We characterized the
composition of phylogenetically reconstructed “clusters”, or groups of people where
multiple transmissions likely occurred, and assessed factors associated with membership in
these clusters among patients diagnosed from 2000–2009.
METHODS
Study Population
We performed a cross-sectional evaluation of patients who had a HIV-1 genotype available
for analysis and who participated in one of two cohorts based on the duration of HIV
infection at diagnosis: (1) “unknown/chronic” or (2) “acute/recent”. The unknown/chronic
cohort includes patients attending the University of North Carolina (UNC) Infectious
Diseases Clinic who enrolled in the UNC Center for AIDS Research HIV Clinical Cohort
1Southern region includes the following states: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky,
Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia
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(UCHCC). An estimated 98% of clinic patients participate in the UCHCC, providing an
accurate representation of the HIV clinic population. To enroll in the UCHCC, participants
must be ≥18 years old and provide written informed consent in English or Spanish.
The acute/recent cohort included patients in the Duke-UNC Acute HIV Consortiumor NC
Screening and Tracing Active Transmission (STAT), statewide programs tracking acute
infections through publicly funded clinics with >99% participation; both have been
previously described in detail[15–17]. Acute infection was defined as either a combination
of non-reactive ELISA or an indeterminate western blot (WB) paired with a positive HIV
RNA or p24 antigen test, or a negative ELISA and WB within 45 days of a positive ELISA
or WB. A recent infection was defined as either (1) a documented negative ELISA or WB
within 45–180 days of a documented positive test, or (2) a positive HIV RNA result, no
detectable evidence of antiretroviral therapy (ART) on the basis of HPLC with ultraviolet
detection (Clinical Pharmacology and Analytical Chemistry Laboratory, UNC CFAR,
Chapel Hill, NC; lower limit of detection 10–25 ng/ml), and results consistent with a
duration of infection <180 days on both a less sensitive ELISA (Vironostika, bioMérieux,
Marcy-l’Étoile, France; standardized optical density cutoff <1.0) and an avidity-modified
third-generation immunoassay (Bio-Rad Laboratories, Hercules, CA; avidity index cutoff
<40).
Sequences and Phylogenetic Reconstruction
Full length protease (PR) and partial reverse transcriptase (RT) sequences were extracted
from commercially performed genotypes obtained for clinical care. For UCHCC patients,
95% of assays were HIV GenoSure® or GenoSure® Plus (Laboratory Corporation of
America®, Research Triangle Park, NC), which spans PR and RT codons 1–400. Sequences
from the acute/recent cohort were derived from GenoSure® or the TRUGENE® HIV-1 assay
(Siemens Healthcare Diagnostics, Tarrytown, NY), which spans PR and RT codons 1–250.
For patients with multiple sequences, only the oldest sequence was used. Sequences were
aligned and edited with Se-Al v2.0[18]. Subtypes were identified using the Subtype
Classification using Evolutionary Algorithms [19]. Only B-subtype sequences, which
represent >98% of subtypes in the area, were included in final analyses. We deposited the
sequences from the UCHCC patients which were used in these analyses into GenBank under
accession numbers JX160108-JX161480. Codon positions associated with major drug
resistance mutations (DRM) according to the IAS-USA 2009 list[20] were initially removed
to avoid potential treatment-induced convergent evolution.
Using a neighbor-joining (NJ) phylogenetic tree, reconstructed under the HKY85 model of
nucleotide substitution [21] in PAUP* v4.0 [22], we selected sequences that differed by
<4.5% pairwise genetic distance from at least one other sequence [11] to scale the dataset to
a manageable size. Transmission clusters were confirmed by Bayesian MCMC inference in
Mr Bayes [23] using the general time reversible model of nucleotide substitution with a
proportion of invariant sites (ι) and gamma distribution of rates (Γ), sample frequency of
every 1000th generation, and a 10% burn-in. Convergence of the estimates was evaluated
with generation vs. log probability plots in Tracer v.1.5[24] using an Effective Sample Size
>200. Due to size constraints, the NJ tree was divided in quarters and each run separately in
Mr Bayes. Maximum clade credibility trees were generated with a 10% burn-in using Tree
Annotator[25]. We further reconstructed a maximum-likelihood (ML) tree (undivided)
under the same model conditions in RAxML v.7.0.4[26], to ensure the quarter trees were
robust. Finally, Bayesian analyses were repeated using complete sequences, evaluating the
third codon position only, for additional confirmation of the phylogenetic clusters. These
confirmatory analyses yielded trees of similar topology to the initial Bayesian trees (data not
shown). To further support identification of “local” clusters, a ML tree was reconstructed in
Fast Tree[27] with all study sequences and an additional 595 controls from the HIV
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Genbank database using Viroblast[28] to identify the top ten related sequences for each
study sequence. Clusters split by control sequences or with inconsistent topology to our
Bayesian or RAxML trees were not considered robust.
Variables
Demographic, risk behavior, and clinical data were abstracted from medical records. The
UCHCC has standardized data extraction methods from medical charts and institutional
databases [29]. We evaluated age at diagnosis, sex, race/ethnicity, year of diagnosis, risk
group, ART exposure, DRMs, and geographic residence. Geographic residence was defined
as living within the primary catchment area for the UNC clinic, determined by a 16
contiguous county area (out of 100 NC counties) where ~75% of UCHCC patients reside.
For ART-naïve individuals, mutations associated with transmitted drug resistance (TDR)
were identified using the 2009 standardized surveillance list from the World Health
Organization [30]. The CD4+ T lymphocyte (CD4) count and HIV RNA viral load closest to
the date of diagnosis were recorded. Transmission risk was categorized as men who have
sex with men (MSM), heterosexual, intravenous drug use (IDU) or other/unknown. Patients
reporting IDU in addition to another risk were classified as IDU.
Outcomes and Definitions
We defined transmission “clusters” and “pairs” as phylogenetic clades with n≥3 and n=2
sequences respectively, and supported by Bayesian posterior probabilities=1. Because we
utilized a relaxed genetic distance definition, we also conducted sensitivity analyses on
clusters which satisfied both Bayesian posterior probabilities=1 and mean intra-cluster
pairwise genetic distance difference of ≤1.5% [31]. Cluster composition was evaluated by
comparing characteristics among members, with “Predominant” clusters defined as those in
which ≥2/3 (66%) of members share the same characteristic. “Homogeneous” clusters were
those in which all members shared a characteristic. Finally, we assessed factors associated
with cluster and pair membership for patients diagnosed from 2000–2009. Although pairs
represent observed transmission, we distinguished between pairs and clusters because many
pairs are identified by partners who enter care together or through partner contact tracing,
and may not necessarily indicate further onward transmission.
Statistical Analyses
For newly diagnosed patients, factors associated with membership in pairs and clusters were
evaluated. Differences in categorical variables were tested with the Pearson’s χ2 test and
continuous variables with the Kruskal-Wallis test. Multivariable analyses were fit using
logistic regression to identify independent predictors of cluster membership. We first fit a
full model based on results of our bivariable analyses and then used backwards elimination
to arrive at a final model that included only factors predictive of cluster membership based




A total of 1694 sequences were available, acquired from 1997–2009, with each sequence
from an individual patient. Of these, 23 (1.4%) sequences were non-B subtypes and
eliminated. The final dataset (n=1671) consisted of 1373 (82%) sequences from the chronic
cohort and 298 (18%) from the acute/recent cohort. In the UCHCC, these patients represent
57% of all participants, which consists of patients diagnosed in the past 20 years with >50%
entering care after 2000. Although genotypes from ART-naive individuals were not
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common until 2007, 312 of these patients had genotypes analyzed from specimens archived
prior to ART-exposure. The UCHCC patients with genotypes were similar to those without
genotypes by sex (71% vs. 69% male; P=0.39), race (both 59% black), and risk (37% vs.
40% MSM, P=0.10). While our dataset includes a minority (estimated <20%) of sequences
from all cases reported to the state in our primary catchment area from 2000–2009, it is
highly representative of these cases by ethnicity (66% black; 7% Latino), sex (72% male),
and risk (41% MSM). Additionally, among our study samples, the race/ethnic distribution
per year (Supplemental Figure 1) was roughly similar to the clinic demographics.
The overall population was 59% black and 72% male, with over half receiving an HIV
diagnosis after 2000 (Table 1). Over half (54%), were ART-naïve at the time of sequence
acquisition and median time from diagnosis to sampling was 658 days (IQR 18–2959). The
newly diagnosed patients consisted of slightly more Latinos (10% vs. 7%), and less patients
reporting IDU (11% vs. 5%) but were otherwise similar to the entire population. Among the
newly diagnosed patients who had a genotype before ART (n=775; 87%), TDR prevalence
was 12%, and TDR was more common among patients diagnosed with acute or recent
infection than those with an unknown duration (17.5% vs. 8.6%; P<0.001).
Transmission Cluster Composition
A total of 557 (33%) of sequences grouped in either 108 pairs (n=216; 13%) or 67 clusters
(n=341; 20%). The phylogenetic tree is shown in Supplemental Figure 2. Clusters ranged
from 3–36 sequences (median 4; IQR 3–5). The median intra-cluster pairwise genetic
distance was 0.020 (IQR 0.012–0.029) nucleotide substitutions/site. Although the majority
of clusters were small, two large clusters (13 and 18 members) with relatively short mean
genetic distances were identified (Figure 1). While most clusters were composed of patients
in the chronic cohort, 42 (63%) clusters included at least one member with acute or recent
infection. Notably, 74% of these clusters included at least one chronic patient diagnosed
prior to the acute/recent(s), suggesting that local transmission may not be dominated by
acute-to-acute. The sensitivity analysis of the more strictly defined 1.5% cutoff yielded 103
pairs (n=206; 12%) and 33 clusters (n=122; 7%) with median 3 members (range 3–13). We
examined cluster composition by various characteristics including race/ethnicity, risk,
duration of infection, age at diagnosis, and presence of TDR. Overall trends were very
similar between the two cluster definitions (Table 2).
Overall, clusters were defined by both racial composition and transmission risk. Most
clusters (n=45; 67%) were predominant black and 19 (28%) were 100% black. A smaller
proportion of clusters were predominant white and none were predominant Latino. Most
Latino sequences (57%) were found in predominant black clusters.
By transmission risk, we found a substantial degree of mixing but also discrete transmission
in both MSM and heterosexual groups. Of predominant risk clusters, 28 (42%) were MSM
and 23 (34%) heterosexual; 12 and 10 of these clusters respectively were
homogeneous(Table 2). Cluster sizes among both groups were similar (mean 3.7 MSM vs.
4.7 heterosexual members; P=0.60). No clusters were predominantly IDU and nearly 25%
were mixed, mostly between heterosexuals and MSM. Among sequences that clustered, 102
(71%) from MSM grouped in predominant MSM clusters while only 5% fell in majority
heterosexual clusters. Of heterosexuals, 91 (60%) grouped in predominant heterosexual
clusters and 9% grouped in predominant MSM clusters. Both black and white women were
equally likely to be members of heterosexual clusters (55% vs. 62%) but among men, blacks
were more likely to be in heterosexual clusters than whites (21% vs. 9%; P=0.02). Among
heterosexual men, 72% of whites and 57% of blacks were in predominant mixed or MSM
clusters (P=0.28).
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Transmission Clusters with Transmitted Drug Resistance
Of all clusters, 17 (25%) included at least one member with TDR. Of these, six had ≥60% of
members with TDR, and in 5 of these, all members shared the same TDR mutation(s) (Table
3), and were among the newly diagnosed subset. These homogenous TDR clusters were
smaller (mean 3.0 vs. 4.2 members; P=0.16) and had significantly smaller mean genetic
distance (0.009 vs. 0.020 substitutions/site; P=0.01) compared to the clusters that had no
members with TDR.
Factors Associated with Membership in Transmission Clusters
Of 889 patients who were newly diagnosed, 154 (17%) and 231 (26%) were members of
pairs and clusters, respectively (Table 4). Generally, no statistically significant differences
were found between patients in pairs and those who were not clustered, though a higher
proportion of Latinos were in pairs. Cluster members were more likely to be younger
(median age 30 [IQR 23–41] vs. 34 [IQR 26–43] years; P<0.001) than non-members.
Latinos were the least likely of all racial/ethnic groups to be clusters members (9% vs. 30%
blacks vs. 24% whites; P<0.001). Those with acute infections were also more likely to be in
clusters (35% vs. 25% chronic; P=0.02) as were patients residing in UNC’s primary
catchment area (27% vs. 22%; P=0.02). Among the 775 ART-naïve patients, 92 (12%) had
TDR. Of these, 33 (36%) were cluster members, a significantly higher proportion compared
to 174 (25%) of cluster members without TDR (P=0.03). All these variables remained
associated with cluster membership in the multivariable regression model (Table 4).
Analysis of the more tightly defined 1.5% clusters showed similar overall trends, though
with reduced levels of statistical significance for some variables due to lower sample size
(Supplemental Table).
DISCUSSION
Our study represents the largest phylogenetic analysis of HIV pol sequences from the
Southeastern US, a region plagued by a substantial burden of HIV/AIDS cases. We found
that in our HIV cohort, representing both chronic and acute infections, 20% of pol sequences
derived from genotypes formed transmission clusters involving three or more individuals
and were delineated primarily by race and, to a lesser extent, risk groups. Although we
observed substantial mixing between MSM and heterosexuals, both groups formed discrete
clusters and were equally likely to contribute to onward transmission among newly
diagnosed patients. In contrast to other studies[32, 33], we found similar cluster sizes among
risk groups as well as several large heterosexual clusters, suggesting that the local
transmission structure is different compared to regions where MSM transmission
predominates. Further, among new patients, non-Latino ethnicity, younger age, acute
infection, presence of TDR, and local residence were all independently associated with
cluster membership. Our results not only offer a glimpse into the structure of local HIV
transmission, but more importantly, pave the foundation for future work exploiting the now
growing repositories of pol sequences in the US.
Within transmission clusters, we observed stronger trends with respect to race, especially
black race, rather than risk groups. While 28% of clusters were exclusively black, only
<18% were exclusively MSM or heterosexual. Few phylogenetic studies to date have
explored racial/ethnic differences in transmission clusters [34, 35] though these methods
have been used to evaluate migration and domestic transmission in Europe [33] and to
assess risk groups[11, 14, 36]. The racial homogeneity of our clusters parallels alternative
analyses showing high rates of assortative sexual mixing, or selecting partners of the same
race/ethnicity, among US blacks[37] and black MSM[38, 39]. The weaker trends seen
among risk groups may be due to several factors. Since risk groups are self-reported, they
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may reflect sexual identity rather than actual routes of infection. Additionally, men who
identify as MSM may still have sex with women[40]. The substantial mixing between risk
groups in our study suggests possible underreporting of MSM or bisexual behavior, which
has been noted in other phylogenetic studies [32]. Among heterosexually-identified men
who were cluster members, the majority of both whites and blacks grouped in predominant
MSM or mixed clusters. We did not find racial differences in the degree of risk group
mixing, further countering the hypothesis that black MSM largely contribute to the
heterosexual epidemic through undisclosed MSM activity [41].
Latinos were much less likely to be members of transmission clusters compared to both
blacks and whites. This finding was surprising, as the sampling density was representative of
our clinic demographics, and because Latinos in NC have nearly three times the HIV
incidence rate compared to whites[2]. Members of potential clusters involving Latinos may
have been missed in our analyses due to under sampling. Alternatively, many infections
among Latinos may have been acquired elsewhere and thus do not cluster in our local
cohort. Latinos in NC are more likely to be foreign-born compared to other regions in the
US[42], and some are seasonal migrants who may have partners residing outside the state.
Latinos did cluster in pairs similarly to other groups, possibly representing partners seeking
care together following infection acquired elsewhere. Future studies tracking migration in
conjunction with phylogenetic analyses may help delineate the structure of transmission
among this hard to reach group.
Among newly diagnosed patients, we found that the presence of TDR, in addition to
younger age and acute infection, was significantly associated with transmission cluster
membership. Notably, the association between TDR and clustering remained significant
even after controlling for infection duration in the multivariable model. These associations
with clustering may simply be markers for very high risk behavior and rapid ongoing
transmission as no data to date suggests TDR mutations make the virus more
transmissible[43]. Additionally, we found several clusters with nearly all individuals
harboring TDR and very few ART-experienced members, suggesting either that experienced
individuals were missed by incomplete sampling or further supporting the role of drug naïve
individuals contributing to onward spread of TDR [44–46]. Importantly, these clusters may
reflect sexual networks that are reservoirs of drug resistance beyond ART-experienced
individuals.
Notably, the reconstruction of transmission clusters on the population level represents an
estimate of the local epidemic. Through incomplete sampling potential cluster members will
be unidentified, either because they are undiagnosed, disengaged from care, or never had a
genotype. Furthermore, the parameters of our analysis were not intended to only identify
linked transmission between partners as there may be unrecognized third parties involved in
the transmission chain and the directionality of transmission cannot be discerned. Although
our use of pol sequences acquired during routine care represents an obvious and unavoidable
selection bias, we had sufficient sampling density to uncover clusters and demonstrate both
expected and unanticipated trends. We used robust statistical support to define our clusters
which could potentially underestimate the number of actual transmission clusters. Although
our less strict genetic distance cut off helps identify clusters where transmission events are
spread out over several years, this method may reveal many historic clusters. Additionally,
we are unable to determine when onward transmission events took place – whether before or
after diagnosis. While we observed clusters predominantly composed of acute/recent
patients [47], a substantial proportion included one or more chronic patients with diagnoses
prior to the acute infection. Importantly, this indicates a failure of secondary prevention and
suggests that acute-acute transmission may not dominate spread in NC; a significant amount
of transmission may occur during chronic infection [48].
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Our study demonstrates a unique view into the structure of local transmission in NC through
the integration of molecular, clinical, and demographic data. These complementary methods
have the potential to provide important insight into relationships that cannot be uncovered
through traditional epidemiological methods alone. These methods may help identify gaps in
case finding and transmission trends among high risk groups including hard to reach
populations, such as Latinos in the Southeast. Ultimately, the integration of widespread
genotypic sampling with epidemiologic data, time-scaling, and sophisticated statistical
methods, could lead to the development of novel models predicating incident cases and
onward transmission – ideal targets for prevention campaigns.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Cluster size distribution and example sections of Bayesian phylogenetic tree showing two
large clusters characterized by risk group. Nodes with posterior probability=1 are indicated.
Numbers at tips represent date of sequencing. Note. MSM, men who have sex with men;
HET, heterosexual; OTH, Other/Unknown risk
A. Distribution of cluster sizes (n≥3 sequences). Median cluster size 4 (IQR 3-5) members.
B. Cluster n=18, Predominant MSM (83%) and Black (78%).
C. Cluster n=13, Homogenous HET (100%) and Predominant Black (69%).
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Table 1
Characteristics of study population with B-subtype sequences for all patients in phylogenetic analyses
(n=1671) and the subset of patients newly diagnosed from 2000-2009 (n=889).
Characteristic All Patients Patients Diagnosed
from 2000–2009
Total n (%) 1671 889
Age at diagnosis, median (IQR) 32 (25–40) 33 (25–43)
Year of Diagnosis, median (IQR) 2000 (1995–2004) 2004 (2002–2006)
Race/Ethnicity
  Black 983 (59) 521 (59)
  White 505 (30) 233 (26)
  Latino 115 (7) 88 (10)
  Othera/Unknown 68 (4) 47 (5)
Sex
  Male 1177 (72) 630 (73)
  Female 460 (28) 226 (26)
Transmission Risk
  MSM 656 (39) 376 (42)
  Heterosexual 688 (41) 377 (42)
  IDU 176 (11) 46 (5)
  Other/Unknown 151 (9) 90 (10)
Duration of infection
  Chronic 1373 (82) 603 (68)
  Recent 129 (8) 125 (14)
  Acute 169 (10) 161 (18)
Sequence < 1 year of diagnosis 777 (47) 712 (80)
CD4 countbc, median cells/mm3 (IQR) --- 251 (49–449)
Viral loadc, median log copies/ml (IQR) --- 4.8 (4.1–5.3)
Antiretroviral History (at the time of sequence)
  Experienced 763 (46) 114 (13)
  Naïve 908 (54) 775 (87)
   Resistanced
    Any DRMs 101 (11) 92 (12)
    NRTIs 41 (5) 34 (4)
    NNRTIs 59 (6) 56 (7)
    PIs 16 (2) 16 (2)
    2 classes 11 (1) 10 (1)
    3 classes 2 (<1) 2 (<1)
Residence in Primary Catchment Areae 1243 (74) 626 (71)
MSM, men who have sex with men; DRMs, drug resistance mutations; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, nonnucleoside
reverse transcriptase inhibitors; PI, protease inhibitors
a
Other race/ethnicity: 1.7% Native American, <1% Asian, <1% Mixed
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b
CD4 counts included for patients in the chronic cohortonly (n=603)
c
Values recorded at date closest to diagnosis
d
Resistance mutations for naïve sequences only
e
Primary catchment area includes 16 out of 100 NC counties that account for approximately 75% of the UNC clinic population. Address
information unavailable for 13 patients.
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Table 2
Cluster composition by selected characteristics among transmission clusters identified by phylogenetic


















    Black 45 (67) 19 (28) 23 (70) 9 (27)
    White 15 (22) 7 (10) 6 (18) 4 (12)
    Latino 0 (0) --- 0 (0) ---
    Other 0 (0) --- 0 (0) ---
    Mixed 7(11) --- 4 (12) ---
Transmission Risk ---
    MSM 28 (42) 12 (18) 16 (48) 8 (24)
    Heterosexual 23 (34) 10 (15) 12 (36) 5 (15)
    IDU/Other/Unknown 0 (0) --- 0 (0) ---
    Mixed 16 (24) --- 5 (15) ---
Age at Diagnosis, years
    <30 26 (39) 9 (13) 14 (42) 10 (30)
    30–44 13 (19) 3 (4) 6 (18) 2 (6)
    ≥45 4 (6) 1 (1) 4 (12) 0 (0)
    Mixed 24 (36) --- 9 (27) ---
Duration of Infection
    Acute or Recent 14 (21) 5 (7) 9 (27) 4 (12)
    Chronic 49 (73) 25 (37) 22 (67) 12 (36)
    Mixed 4 (6) --- 2 (6) ---
TDR
    Yes 5 (7) 5 (7) 4 (12) 4 (12)
    No 62 (93) 50 (75) 29 (88) 27 (82)
Predominant, ≥2/3 of members share same characteristic; Homogeneous, 100% of members share same characteristic; Mixed, no characteristic in
cluster predominant. MSM, men who have sex with men; IDU, injection drug use; TDR, transmitted drug resistance
a
Mean intra-cluster pairwise genetic distance (nucleotide substitutions per site)
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